A review of the development of large-vessel disease in diabetes mellitus

The American Journal of Medicine

Volumn 85, Issue 5 SUPPL. 1, 1988, Pages 113-118

  Colwell, John A ^a   Lopes Virella, Maria F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN;

ATHEROSCLEROSIS; ENDOTHELIUM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE FUNCTION;

ANIMAL; ARTERIOSCLEROSIS; BLOOD PLATELETS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMAN; LIPIDS; LIPOPROTEINS; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0024246469     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(88)90403-2     Document Type: Article

References (55)

1. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus
2. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus
3. Pathogenesis of atherosclerosis in diabetes mellitus
4. The pathogenesis of atherosclerosis—an update
5. The pathogenesis of atherosclerosis
6. The pathogenesis of atherosclerosis
7. Increased platelet aggregation in diabetes mellitus
8. Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease
9. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients
10. Enhancement of platelet aggregation by low density lipoproteins (LDL) from patients with insulin-dependent diabetes mellitus (IDDM)
11. Increased synthesis of prostaglandin E-like material by platelets from patients with diabetes mellitus
12. Increased platelet thromboxane synthesis in diabetes mellitus
13. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients
14. Platelet survival in streptozotocin-induced diabetic rats
15. V.A. cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates
16. Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study
17. Quantitative studies of von Willebrand factor (vWF) in normal and diabetic subjects: role of vWF in second-phase platelet aggregation
18. Increased platelet aggregation in early diabetes mellitus
19. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control
20. Effect of metabolic control on lipid, lipoprotein and apolipoprotein levels in 55 insulin-dependent diabetic patients—a longitudinal study
21. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients
22. High density lipoproteins in diabetes
23. Serum high density lipoprotein in diabetes
24. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study
25. Diabetes, blood lipids and the role of obesity in coronary heart disease risk in women
26. The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and noninsulin-dependent diabetes
27. Plasma triglyceride and fatty acid metabolism in diabetes mellitus
28. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects
29. Composition of serum very low density lipoproteins in diabetes
30. Lipoprotein patterns in diet, sulphonylurea, and insulin-treated diabetics
31. Dietary effects on very low density lipoproteins in type II (non-insulin dependent) diabetes mellitus
32. Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells
33. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages
34. Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages
35. VLDL and LDL from diabetic patients stimulate increased CE synthesis in human monocyte-derived macrophages
36. Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte-macrophages: a saturable pathway distinct from the LDL receptor
37. Non-enzymatic glycosylation of LDL alters its biologic activity
38. Plasma apolipoproteins AI, AII, B, CI and E are glucosylated in hyperglycemic diabetic subjects
39. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type I (insulin-independent) diabetic patients: changes with metabolic control
40. Metabolism of LDL from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts
41. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type I (insulin-dependent) diabetic patients: the influence of nonenzymatic glycosylation of low-density lipoproteins
42. Glycosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages
43. Metabolic activity of diabetic monocytes
44. Regulation of cellular sterol flux and synthesis by human serum lipoproteins
45. The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cell fractions of human high density apoproteins
46. Serum high density lipoprotein in diabetic patients
47. Non-enzymatic glucosylation of HDL accelerates its catabolism in guinea pigs
48. Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoabsorption of apolipoprotein E
49. Increased free cholesterol in plasma low and very low density lipoproteins in noninsulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer
50. Abnormal composition of high-density lipoproteins in non-insulin-dependent diabetics
51. Specific high affinity binding of HDL to cultured human skin fibroblasts and arterial smooth muscle cells
52. Regulation of high density lipoprotein binding activity of aortic endothelial cells by treatment with acetylated low density lipoprotein
53. Binding of HDL to cultured fibroblasts after chemical alteration of apoprotein amino acid residues
54. Diabetic lipoprotein deficient sera: its effect in LDL uptake and degradation by fibroblasts